Gryphon Financial Partners LLC Has $322,000 Position in Danaher Co. (NYSE:DHR)

Gryphon Financial Partners LLC decreased its position in Danaher Co. (NYSE:DHR) by 51.2% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 1,404 shares of the conglomerate’s stock after selling 1,471 shares during the period. Gryphon Financial Partners LLC’s holdings in Danaher were worth $322,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently bought and sold shares of the company. Heck Capital Advisors LLC acquired a new stake in shares of Danaher in the fourth quarter valued at approximately $27,000. Decker Retirement Planning Inc. acquired a new stake in Danaher in the 4th quarter valued at $31,000. Golden State Wealth Management LLC bought a new stake in Danaher during the 4th quarter worth about $31,000. Strategic Financial Concepts LLC acquired a new position in shares of Danaher during the 4th quarter worth about $31,000. Finally, Pineridge Advisors LLC grew its holdings in shares of Danaher by 63.3% in the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock valued at $34,000 after acquiring an additional 57 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Danaher Trading Down 1.0 %

Shares of DHR stock opened at $205.60 on Tuesday. The stock has a 50 day simple moving average of $224.11 and a 200 day simple moving average of $244.31. Danaher Co. has a 1 year low of $196.80 and a 1 year high of $281.70. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The stock has a market cap of $146.94 billion, a P/E ratio of 38.94, a price-to-earnings-growth ratio of 2.66 and a beta of 0.83.

Danaher (NYSE:DHR) last released its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter last year, the company posted $2.09 EPS. On average, research analysts predict that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be given a $0.32 dividend. The ex-dividend date is Friday, March 28th. This is a boost from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a dividend yield of 0.62%. Danaher’s payout ratio is presently 24.24%.

Insider Buying and Selling

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the sale, the senior vice president now directly owns 20,230 shares in the company, valued at $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 11.10% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on DHR shares. Citigroup dropped their target price on Danaher from $285.00 to $265.00 and set a “buy” rating on the stock in a report on Thursday, January 30th. Bank of America raised shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 target price for the company in a research note on Friday, December 13th. Scotiabank began coverage on shares of Danaher in a research report on Monday, December 23rd. They set a “sector perform” rating and a $265.00 price target on the stock. The Goldman Sachs Group set a $250.00 target price on shares of Danaher in a research note on Wednesday, January 15th. Finally, Wells Fargo & Company lowered their price target on Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a research report on Thursday, January 30th. Seven investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and an average target price of $278.00.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.